Drug safety: withdrawn medications are only part of the pictureReport as inadecuate




Drug safety: withdrawn medications are only part of the picture - Download this document for free, or read online. Document in PDF available to download.

BMC Medicine

, 14:28

First Online: 13 February 2016Received: 27 January 2016Accepted: 08 February 2016DOI: 10.1186-s12916-016-0579-5

Cite this article as: Rawson, N.S.B. BMC Med 2016 14: 28. doi:10.1186-s12916-016-0579-5

Abstract

AbstractIn a research article published in BMC Medicine, Onakpoya and colleagues provide a historical review of withdrawals of medications for safety reasons. However, withdrawn medications are only one part of the picture about how regulatory agencies manage drug risks. Moreover, medications introduced before the increased pre-marketing regulations and post-marketing monitoring systems instituted after the thalidomide tragedy have little relevance when considering the present drug safety picture because the circumstances under which they were introduced were completely different. To more fully understand drug safety management and regulatory agency actions, withdrawals should be evaluated within the setting and timeframe in which the medications are approved, which requires information about approvals and safety warnings. Studies are needed that provide a more comprehensive current picture of the identification and evaluation of drug safety risks as well as how regulatory agencies deal with them.

Please see related research article: http:-bmcmedicine.biomedcentral.com-articles-10.1186-s12916-016-0553-2

KeywordsDrug safety Adverse drug reaction Drug withdrawal Drug discontinuation  Download fulltext PDF



Author: Nigel S. B. Rawson

Source: https://link.springer.com/







Related documents